Off-patent Drugs Bill
A Bill to require the Secretary of State to seek licences for off-patent drugs in new indications; to require the National Institute for Health and Care Excellence to conduct technology appraisals for off-patent drugs in new indications; and for connected purposes.
Last fetched 25 Apr 2026 · parliament.uk
Progress through Parliament2 stages recorded
Commons
1st reading
24 Jun 2015
Commons
2nd reading
06 Nov 2015
DocumentsOpen on parliament.uk →